Prognostic factors and treatment outcomes in patients with operated endometrial cancer: analysis of 674 patients at a single institution

被引:0
作者
Yoney, A. [1 ]
Yildirim, C. [1 ]
Isikli, L. [1 ]
Unsal, M. [1 ]
机构
[1] Okmeydani Training & Res Hosp, Dept Radiat Oncol, TR-34384 Istanbul, Turkey
来源
JOURNAL OF BUON | 2011年 / 16卷 / 01期
关键词
endometrial carcinoma; grade; myometrial invasion; postoperative treatment; PHASE-III TRIAL; WHOLE-ABDOMINAL IRRADIATION; EXTERNAL-BEAM RADIOTHERAPY; FIGO STAGE-I; ADJUVANT CHEMOTHERAPY; VAGINAL BRACHYTHERAPY; INTERMEDIATE-RISK; RADIATION-THERAPY; MRC ASTEC; CARCINOMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Endometrial carcinoma is the most prevalent gynecologic tumor in developed countries. The aim of the present study was to evaluate the clinical characteristics of the patients with endometrial cancer Methods: Six hundred and seventy-four patients who had received postoperative therapy were retrospectively investigated. Of the cases, 186 were only monitored, whereas 43 received intracavitary radiotherapy (ICRT) and 54 external beam radiotherapy (EBRT). Two hundred and fifty-nine patients received both EBRT plus ICRT. Eight patients received chemotherapy (CT), whereas 24 patients received both CT and EBRT plus ICRT. Results: Statistical analyses revealed that age, menopausal status, tumor histology, stage, grade, tumor diameter, myometrial invasion, lymphovascular space invasion (LVI), positive cytology of abdominal fluid/washings, omental involvement, adnexal involvement and the type of the therapy significantly affected both the overall survival (OS) and disease-free survival (DFS). Survival was poor in patients over 60 years of age, who had advanced stage (higher than FIGO stage 2a), grade III tumor and myometrial invasion >50%. Conclusion: Age was the most important factor associated with local relapse while survival was affected by age, grade, myometrial invasion and stage.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 45 条
[1]  
AALDERS J, 1980, OBSTET GYNECOL, V56, P419
[2]  
Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO
[3]  
2-Y
[4]   Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer [J].
Alektiar, Kaled M. ;
Makker, Vicky ;
Abu-Rustum, Nadeem R. ;
Soslow, Robert A. ;
Chi, Dennis S. ;
Barakat, Richard R. ;
Aghajanian, Carol A. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :142-145
[5]   Is endometrial carcinoma intrinsically more aggressive in elderly patients? [J].
Alektiar, KM ;
Venkatraman, E ;
Abu-Rustum, N ;
Barakat, RR .
CANCER, 2003, 98 (11) :2368-2377
[6]  
[Anonymous], 2005, Obstet Gynecol, V106, P413, DOI DOI 10.1097/00006250-200508000-00050
[7]   Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Baekelandt, M. M. ;
Castiglione, M. .
ANNALS OF ONCOLOGY, 2009, 20 :29-31
[8]   Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis [J].
Blake, P. ;
Swart, Ann Marie ;
Orton, J. ;
Kitchener, H. ;
Whelan, T. ;
Lukka, H. ;
Eisenhauer, E. ;
Bacon, M. ;
Tu, D. ;
Parmar, M. K. B. ;
Amos, C. ;
Murray, C. ;
Qian, W. .
LANCET, 2009, 373 (9658) :137-146
[9]   Lymphadenectomy in endometrioid uterine cancer staging - How many lymph nodes are enough? A study of 11,443 patients [J].
Chan, John K. ;
Urban, Renata ;
Cheung, Michael K. ;
Shin, Jacob Y. ;
Husain, Amreen ;
Teng, Nelson N. ;
Berek, Jonathan S. ;
Walker, Joan L. ;
Kapp, Daniel S. ;
Osann, Kathryn .
CANCER, 2007, 109 (12) :2454-2460
[10]   ENDOMETRIAL PAPILLARY ADENOCARCINOMAS - 2 CLINICOPATHOLOGICAL TYPES [J].
CHEN, JL ;
TROST, DC ;
WILKINSON, EJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1985, 4 (04) :279-288